Verano HoldingsVRNOD +0.19%65 FCF Margin % is 1.75% as of Mar. 2026, which is 1% above its 10-year median of 1.73. GuruFocus rates VRNOD with a GF Score™ of 65/100 and a GF Value™ of $7.76 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 958 Drug Manufacturers companies, Verano Holdings ranks better than 53.44% on this metric.
The historical rank and industry rank for Verano Holdings's FCF Margin % or its related term are showing as below:
VRNOD'
s FCF Margin % Range Over the Past 10 Years
Min: -2.82 Med: 1.73 Max: 7.82
Current: 3.34
During the past 7 years, the highest FCF Margin % of Verano Holdings was 7.82%. The lowest was -2.82%. And the median was 1.73%.
VRNOD's FCF Margin % is ranked better than 53.44% of 958
companies
in the Drug Manufacturers industry
Industry Median: 2.51
vs VRNOD: 3.34
Verano Holdings FCF Margin % Related Terms
Verano Holdings FCF Margin % Historical Data
* Premium members only.
The historical data trend for Verano Holdings's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Verano Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Verano Holdings FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Verano Holdings's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Verano Holdings's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Verano Holdings (VRNOD) has a FCF Margin % of 1.75% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Verano Holdings and its competitors. This is near median its historical median of 1.73. According to the industry distribution chart, Verano Holdings ranks #446 out of 958 companies in the Drug Manufacturers industry, placing it in the top 46.6%.
Is Verano Holdings' FCF Margin % too high?
Verano Holdings' current FCF Margin % of 1.75% is near median its 10-year median of 1.73. The Drug Manufacturers industry median FCF Margin % is 2.51. Verano Holdings' value of 1.75% is 30.3% below this industry median. Based on the distribution chart, Verano Holdings ranks #446 out of 958 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Verano Holdings has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Verano Holdings' FCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Verano Holdings ranks #446 out of 958 companies for FCF Margin %. This puts Verano Holdings in the upper half of its industry. The industry median FCF Margin % is 2.51. Verano Holdings' value of 1.75% is 30.3% below this benchmark. While the company's 10-year median is 1.73 vs. the industry median of 2.51, Verano Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Verano Holdings's current FCF Margin % of 1.75% is 30.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Verano Holdings and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Verano Holdings's current FCF Margin % is 1.75%, which is near median its own 10-year median of 1.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Verano Holdings stock overvalued right now?
Based on GuruFocus' analysis, Verano Holdings (VRNOD) is currently considered Possible Value Trap. The stock's GF Value™ is $7.76, compared to a current price of $5.31 — trading 31.6% below its estimated fair value. The current FCF Margin % is 1.75%, which is near median its 10-year median of 1.73 and 30.3% below the Drug Manufacturers industry median of 2.51. Verano Holdings' overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Verano Holdings (VRNOD), the current FCF Margin % is 1.75% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Verano Holdings (VRNOD) Overvalued in 2026?
Based on GuruFocus' analysis, Verano Holdings stock appears to be undervalued.
The current stock price of $5.31 is trading 31.6% below its estimated GF Value™ of $7.76.
GuruFocus considers Verano Holdings to be Possible Value Trap.
Key valuation signals for VRNOD:
FCF Margin %: 1.75% (near median its 10-year median of 1.73)
GF Value™: $7.76 vs. price of $5.31 (31.6% below fair value)
Industry Position: 30.3% below the Drug Manufacturers median (#446 of 958)
No single metric tells the full story. See the VRNOD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Verano Holdings Corp is a vertically integrated, multi-state cannabis operator in the United States. The company operates through cultivation (wholesale) and retail segments. Its consumer brands include Encore, Avexia, MUV, Savvy, BITS, and Verano, while its retail dispensaries operate under brands such as Zen Leaf and MUV. The company derives the majority of its revenue from the retail segment.
65GF Score
Get the complete analysis for VRNOD
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VRNOD has been successfully added to your 
